{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:57:21Z","timestamp":1774007841735,"version":"3.50.1"},"reference-count":102,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Cardiovascular diseases (CVD) are the most important cause of morbidity and mortality in the general population. Because the high prevalence of COVID-19 and chronic Chagas disease (CCD) where the latter is endemic, all such diseases will likely be observed in the same patient. While COVID-19 can provoke generalized endotheliitis, which can lead to a cytokine storm and a hyper-coagulable state culminating into in-site and at a distance thrombosis. Therefore, small-vessel coronary artery disease (CAD), cerebrovascular disease, thromboembolism, and arrhythmias are prominent findings in COVID-19. In CCD, small-vessel CAD, cardioembolic stroke, pulmonary embolism, heart failure and arrhythmias are frequently observed as a result of a similar but less intense mechanism. Consequently, the association of CCD and COVID-19 will likely increase the incidence of CVD. Thus, doctors on the frontline should be on the alert for this diagnostic possibility so that the proper treatment can be given without any delay.<\/jats:p>","DOI":"10.3389\/fmed.2022.910388","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T05:09:35Z","timestamp":1656479375000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Management of Cardiovascular Disease in Patients With COVID-19 and Chronic Chagas Disease: Implications to Prevent a Scourge Still Larger"],"prefix":"10.3389","volume":"9","author":[{"given":"Reinaldo Bulgarelli","family":"Bestetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edimar Alcides","family":"Bocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Bestetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Sarli","family":"Issa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary Aparecida","family":"Furlan-Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Arruda","family":"Nakazone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"B1","year":"2022","journal-title":"Worldometers.info\/Coronavirus."},{"key":"B2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European society of cardiology: cardiovascular disease statistics 2019","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur Heart J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.jacc.2017.08.004","article-title":"Chronic Chagas heart disease management: from etiology to cardiomyopathy treatment","volume":"70","author":"Bocchi","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0167-5273(92)90236-V","article-title":"Clinical characteristics of acute myocardial infarction in patients with Chagas disease","volume":"35","author":"Bestetti","year":"1992","journal-title":"Int J Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jacc.2021.10.035","article-title":"Coronary atherosclerotic plaque regression","volume":"79","author":"Dawson","year":"2022","journal-title":"JACC."},{"key":"B6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/CRD.0000000000000385","article-title":"Cardiovascular and cerebrovascular complications with COVID-19","volume":"29","author":"Greenberg","year":"2021","journal-title":"Cardiol Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e2021512","DOI":"10.23750\/abm.v92i5.12013","article-title":"How stable ischemic heart disease leads to acute coronary syndrome in COVID-19?","volume":"92","author":"Shafeghat","year":"2021","journal-title":"Acta Biom."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1002\/ccd.29056","article-title":"Severe coronary spasm in a COVID-19 patient","volume":"97","author":"Rivero","year":"2021","journal-title":"Catheter Cardiovasc Interv."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.jacc.2020.07.022","article-title":"High thrombus burden in patients with COVD-19 presenting with ST-segment elevation myocardial infarction","volume":"76","author":"Choudry","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ijcard.2014.07.112","article-title":"Precordial chest pain in patients with chronic Chagas disease","volume":"176","author":"Bestetti","year":"2014","journal-title":"Int J Cardiol."},{"key":"B11","first-page":"153","article-title":"Esophageal etiology of precordial pain in chagasic patients","volume":"64","author":"Lopes","year":"1995","journal-title":"Arq Bras Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/0002-9149(92)90505-S","article-title":"Myocardial perfusion abnormalities in chronic Chagas disease as detected by thallium-201 scintigraphy","volume":"69","author":"Marin-Neto","year":"1992","journal-title":"Am J Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/0002-8703(85)90598-8","article-title":"Increased capacity of the coronary arteries in chronic Chagas heart disease: further support for the neurogenic pathogenesis concept","volume":"109","author":"Oliveira","year":"1985","journal-title":"Am Heart J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1590\/S0066-782X2011005000103","article-title":"Asymptomatic coronary artery disease in chagasic patients with heart failure: prevalence and risks factor","volume":"97","author":"Carvalho","year":"2011","journal-title":"Arq Bras Cardio."},{"key":"B15","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/0002-8703(95)90122-1","article-title":"Coronary vascular activity is abnormal in patients with chronic Chagas heart disease","volume":"129","author":"Torres","year":"1995","journal-title":"Am Heart J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jcmg.2008.09.012","article-title":"Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas cardiomyopathy","volume":"2","author":"Hiss","year":"2009","journal-title":"JACC Img."},{"key":"B17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0002-8703(90)90191-Y","article-title":"Microvascular changes as a cause of chronic cardiomyopathy in Chagas disease","volume":"120","author":"Rossi","year":"1990","journal-title":"Am Heart J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(96)91403-8","article-title":"Role of parasites in the pathogenesis of Chagas cardiomyopathy","volume":"347","author":"Bestetti","year":"1996","journal-title":"Lancet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0181","DOI":"10.1590\/0037-8682-0181-2021","article-title":"Aspirin plus verapamil relieves angina and perfusion abnormalities in patients with coronary microvascular dysfunction and Chagas disease: a pilot non-randomized study","volume":"54","author":"Pav\u00e3o","year":"2021","journal-title":"Rev Soc Med Trop."},{"key":"B20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/cvr\/24.7.521","article-title":"Effects of long-term metoprolol administration on the electrocardiogram of rats infected with T","volume":"24","author":"Bestetti","year":"1990","journal-title":"cruzi. Cardiovasc Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1007\/s00415-021-10406-y","article-title":"Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)","volume":"268","author":"Harapan","year":"2021","journal-title":"J Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/ene.14535","article-title":"Increased risk of acute stroke among patients with severe COVID-19: a multicentre study and meta-analysis","volume":"28","author":"Siepmman","year":"2021","journal-title":"Eur J Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12877-021-02006-2","article-title":"Incidence, characteristics, and clinical relevance of acute stroke in old patients hospitalized with COVID-19","volume":"21","author":"Mendes","year":"2021","journal-title":"BMC Geriatr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/STROKEAHA.120.031668","article-title":"Acute cerebrovascular events with COVID-19 infection","volume":"52","author":"Dhamoon","year":"2021","journal-title":"Stroke."},{"key":"B25","doi-asserted-by":"publisher","first-page":"105068","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105068","article-title":"Acute stroke care in a New York city comprehensive stoke center during the COVID-19 pandemic","volume":"29","author":"Agarwal","year":"2020","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2143\/AC.55.1.2005715","article-title":"Stroke in a hospital-derived cohort of patients with chronic Chagas disease","volume":"55","author":"Bestetti","year":"2000","journal-title":"Acta Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0167-5273(85)90262-1","article-title":"Life expectancy analysis in patients with Chagas disease; prognostic after on decade (1973-1983)","volume":"8","author":"Espinosa","year":"1985","journal-title":"Int J Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.gheart.2015.07.006","article-title":"Prevalence and risk factors for embolic cerebrovascular events associated with Chagas heart disease","volume":"10","author":"Nunes","year":"2015","journal-title":"Glob Heart."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.07.007","article-title":"Etiological classification of stroke in patients with Chagas disease using TOAST, causative classification system TOAST, and ASCOD phenotyping","volume":"26","author":"Bezerra","year":"2017","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"106034","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106034","article-title":"Artificial inteligence based- decision for the prediction of cardioembolism in patients with Chagas disease and ischemic stroke","volume":"30","author":"Montanaro","year":"2021","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1474-4422(10)70042-9","article-title":"Chagas disease and stroke","volume":"9","author":"Carod-Artal","year":"2010","journal-title":"Lancet Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1177\/17474930211006284","article-title":"Chagas disease is an independent predictor of stroke and death in a cohort of heart failure patients","volume":"17","author":"Silva","year":"2022","journal-title":"Int J Stroke."},{"key":"B33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0002-9149(83)90085-1","article-title":"Cardiac thrombosis and thromboembolism in chronic Chagas heart disease","volume":"52","author":"Oliveira","year":"1983","journal-title":"Am J Cardiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1002\/ehf2.12805","article-title":"Detection of viral SASRS-CoV-2 genomes and histopathological changes in endomyocardial biopsies","volume":"7","author":"Escher","year":"2020","journal-title":"ESC Heart Fail."},{"key":"B36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/jmcb\/mjaa064","article-title":"COVID-19 and cardiovascular diseases","volume":"13","author":"Liu","year":"2021","journal-title":"J Mol Cell Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1002\/ehf2.13549","article-title":"Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry","volume":"8","author":"Sokoslki","year":"2021","journal-title":"ESC Heart Fail."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.4269\/ajtmh.20-1185","article-title":"Case report: COVID-19 and Chagas disease in two coinfected patients","volume":"103","author":"Alberca","year":"2020","journal-title":"Am J Trop Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1001\/jama.2021.24868","article-title":"Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 omicron wave compared with previous waves","volume":"327","author":"Maslo","year":"2022","journal-title":"JAMA."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/ehf2.13232","article-title":"The course of patients with Chagas heart disease during episodes of decompensated heart failure","volume":"8","author":"Issa","year":"2021","journal-title":"ESC Heart Fail."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1002\/ejhf.1990","article-title":"Heart failure in COVID-19 patients: prevalence, incidence, and prognostic implications","volume":"22","author":"Rey","year":"2020","journal-title":"Eur J Heart Fail."},{"key":"B42","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/ehf2.13199","article-title":"Worsening of heart failure by coronavirus disease 2019 is associated with high mortality","volume":"8","author":"Bocchi","year":"2021","journal-title":"ESC Heart Fail."},{"key":"B43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ijcard.2009.02.011","article-title":"Mortality indicators among chronic Chagas patients living in an endemic area","volume":"143","author":"Gon\u00e7alves","year":"2010","journal-title":"Int J Cardiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000177142","article-title":"Predictors of sudden cardiac death for patients with Chagas' disease: a hospital-derived cohort study","volume":"87","author":"Bestetti","year":"1996","journal-title":"Cardiology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1002\/ehf2.12770","article-title":"The use of the CALL risk score for predicting mortality in Brazilian heart failure patients","volume":"7","author":"Nakazone","year":"2020","journal-title":"ESC Heart Fail"},{"key":"B46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijcard.2007.11.057","article-title":"Predictors of all-cause mortality in chronic Chagas heart in the current era of heart failure therapy","volume":"128","author":"Theodoropoulos","year":"2008","journal-title":"Int J Cardiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.healun.2009.10.014","article-title":"Prognostic impact of Chagas disease in patients awaiting heart transplantation","volume":"29","author":"Bertolino","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"B48","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1590\/S0066-782X2011005000112","article-title":"Comparison of outcome between Chagas cardiomyopathy and Idiopathic Dilated Cardiomyopathy","volume":"97","author":"Barbosa","year":"2011","journal-title":"Arq Bras Cardiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e004361","DOI":"10.1161\/CIRCHEARTFAILURE.117.004361","article-title":"Contemporary characteristics and outcomes in Chagasic heart failure compared with other nonischemic and ischemic cardiomyopathy","volume":"10","author":"Shen","year":"2017","journal-title":"Circ Heart Fail"},{"key":"B50","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5935\/abc.20180190","article-title":"Diretriz Brasileira de Insufici\u00eancia Card\u00edaca Cr\u00f4nica e Aguda","volume":"111","author":"Rhode","year":"2018","journal-title":"Arq Bras Cardiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/ehf2.12344","article-title":"Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post-hoc analysis of the SHIFT trial","volume":"5","author":"Bocchi","year":"2018","journal-title":"ESC Heart Fail."},{"key":"B52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5603\/CJ.a2020.0038","article-title":"Does left ventricular reverse remodelling influence long-term outcomes in patients with Chagas cardiomyopathy?","volume":"29","author":"Nakazone","year":"2022","journal-title":"Cardiol J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.17987\/icfj.v7i0.217","article-title":"The treatment of chronic heart failure secondary to Chagas cardiomyopathy in the contemporary era","volume":"7","author":"Bestetti","year":"2016","journal-title":"Int Cardiovasc Forum J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"20289","DOI":"10.1038\/s41598-021-96825-3","article-title":"Chagas disease and SARS-CoV-2 coinfection does not lead to worse in-hospital outcomes","volume":"11","author":"Molina","year":"2021","journal-title":"Sci Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cardfail.2009.09.005","article-title":"Plasma ACE2 activity is an independent prognostic marker in Chagas disease and equally potent as BNP","volume":"16","author":"Wang","year":"2010","journal-title":"J Cardiac Fail."},{"key":"B56","doi-asserted-by":"publisher","first-page":"107257","DOI":"10.1016\/j.carpath.2020.107257","article-title":"Kinins and nitric oxide in patients with chronic Chagas disease and systemic arterial hypertension","volume":"49","author":"Dellalibera-Joviliano","year":"2020","journal-title":"Cardiovasc Pathol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet."},{"key":"B58","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3855\/jidc.14580","article-title":"Nonpharmaceutical public health interventions to curb the COVID-19 pandemic: a narrative review","volume":"16","author":"Bestetti","year":"2022","journal-title":"J Infect Dev Ctries."},{"key":"B59","first-page":"129","article-title":"Pulmonary embolism, part I. Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism","volume":"18","author":"Belohl\u00e1vek","year":"2013","journal-title":"Exp Clin Cardiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1093\/eurheartj\/ehaa500","article-title":"Pulmonary embolism in COVID-19 patients: a French multicentre cohort study","volume":"41","author":"Fauvel","year":"2020","journal-title":"Eur Heart J."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1007\/s42399-020-00605-5","article-title":"Prevalence of pulmonary embolism in COVID-19: a pooled analysis","volume":"2","author":"Desai","year":"2020","journal-title":"SN Compr Clin Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijcard.2020.04.028","article-title":"Acute pulmonary embolism in COVID-19 disease: preliminary report on seven patients","volume":"313","author":"Faggiano","year":"2020","journal-title":"Int J Cardiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","article-title":"Pulmonary post-mortem findings in a series of COVID-19 cases from Northern Italy: a two centre descriptive studies","volume":"20","author":"Carsana","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ijid.2021.07.001","article-title":"COVID-10 and sudden community deaths in Lusaka, Zambia, Africa \u2013 A medico-legal whole-body autopsy case series","volume":"109","author":"Mucheleng'anga","year":"2021","journal-title":"Int J Infect Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1001\/jama.2021.4152","article-title":"Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit","volume":"325","author":"Sadeghipour","year":"2021","journal-title":"JAMA."},{"key":"B66","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with COVID-19","volume":"385","author":"Lawler","year":"2021","journal-title":"N Engl J Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e237046","DOI":"10.1136\/bcr-2020-237046","article-title":"Catheter-directed thrombolysis to treat acute pulmonary thrombosis in a patient with COVID-19 pneumonia","volume":"13","author":"Pendower","year":"2020","journal-title":"BMJ Case rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.carpath.2018.04.004","article-title":"Thromboembolic findings in patients with heart failure at autopsy","volume":"35","author":"Macedo","year":"2018","journal-title":"Cardiovasc Pathol."},{"key":"B69","first-page":"189","article-title":"Cardiac thrombosis and embolism in patients having died of chronic Chagas cardiopathy","volume":"52","author":"Fernandez","year":"1989","journal-title":"Arq Bras Cardiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/AC.66.1.2064969","article-title":"Massive right-sided cardiac thrombosis in Chagas heart disease without left ventricular dysfunction","volume":"66","author":"Bestetti","year":"2011","journal-title":"Acta Cardiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1590\/S0066-782X2010005000146","article-title":"Study of pro-thrombotic and pro-inflammatory factors in Chagas cardiomyopathy","volume":"95","author":"Melo","year":"2010","journal-title":"Arq Bra Cardiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1007\/s11010-021-04204-3","article-title":"Immunothrombotic dysregulation in Chagas disease and COVID-19: a comparative study of anticoagulation","volume":"476","author":"Mayoral","year":"2021","journal-title":"Mol Cell Bioch."},{"key":"B73","first-page":"678","article-title":"A preliminary study of platelet hyperactivity in the chronic indeterminate phase of Chagas disease","volume":"35","author":"Castillejos","year":"2018","journal-title":"Trop Biomed."},{"key":"B74","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/09537104.2019.1667496","article-title":"Human platelet antigen polymorphisms and the risk of chronic Chagas disease cardiomyopathy","volume":"31","author":"Correa","year":"2020","journal-title":"Platelets."},{"key":"B75","doi-asserted-by":"publisher","first-page":"315","DOI":"10.31083\/j.rcm.2020.03.126","article-title":"Endothelial dysfunction contributes to COVID-19- associated vascular inflammation and coagulopathy","volume":"21","author":"Zhang","year":"2020","journal-title":"Rev Cardiovasc Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5123\/S1679-49742016000500002","article-title":"Second Brazilian Consensus on Chagas disease","volume":"25","author":"Dias","year":"2016","journal-title":"Epidemiol Serv Sa\u00fade"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2333721419859687","article-title":"Prevalence and incidence of atrial fibrillation and other arrhythmias in the general older population: findings from the Swedish national study on aging and care","volume":"5","author":"Lindberg","year":"2019","journal-title":"Gerontol Geriat Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e006273","DOI":"10.1161\/CIRCEP.118.006273","article-title":"Frequency of cardiac rhythm abnormalities inn a half million adults","volume":"11","author":"Khurshid","year":"2018","journal-title":"Circ Arrhyth Electrophysiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12872-016-0210-x","article-title":"Incidence and timing of potentially high-risk arrhythmias detected through long-term continuous ambulatory electrocardiographic monitoring","volume":"16","author":"Solomon","year":"2016","journal-title":"BMC Cardiovasc Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e004662","DOI":"10.1161\/CIRCEP.116.004662","article-title":"Incidence of idiopathic ventricular arrhythmias: a population-based study","volume":"10","author":"Sirichand","year":"2017","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pcad.2008.06.003","article-title":"Epidemiology of sudden cardiac death: clinical and research implications","volume":"51","author":"Chugh","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1253\/circj.CJ-16-0602","article-title":"Ventricular fibrillation in a general population","volume":"80","author":"Tseng","year":"2016","journal-title":"Circ J"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/CM9.0000000000000744","article-title":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province","volume":"133","author":"Liu","year":"2020","journal-title":"Chin Med J."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e008920","DOI":"10.1161\/CIRCEP.120.008920","article-title":"Malignant arrhythmias in patients with COVID-19","volume":"13","author":"Turagam","year":"2020","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0167-5273(90)90006-Q","article-title":"Ventricular arrhythmias and left ventricular myocardial function in chronic chagasic patients","volume":"28","author":"Carrasco","year":"1990","journal-title":"Int J Cardiol."},{"key":"B88","first-page":"377","article-title":"Arritmias ventriculares na doen\u00e7a de Chagas. Particularidades diagn\u00f3sticas, progn\u00f3sticas e terap\u00eauticas","volume":"65","author":"Rassi-Jr","year":"1995","journal-title":"Arq Bras Cardiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1590\/S0066-782X2000000700004","article-title":"Predictive value of clinical and electrophysiological variables in patients with chronic chagasic cardiomyopathy and nonsustained ventricular tachycardia","volume":"75","author":"Silva","year":"2000","journal-title":"Arq Bras Cardiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0167-5273(90)90271-6","article-title":"Clinical profile of patients with Chagas disease before and during sustained ventricular tachycardia","volume":"29","author":"Bestetti","year":"1990","journal-title":"Int J Cardiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1540-8159.2006.00377.x","article-title":"Automatic implantable cardioverter-defibrillators in Chagas heart disease patients with malignant ventricular arrhythmias","volume":"29","author":"Cardinalli-Neto","year":"2006","journal-title":"PACE."},{"key":"B92","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0167-5273(94)90087-6","article-title":"Prognostic implications of clinical, electrocardiographic and hemodynamic findings in chronic Chagas disease","volume":"43","author":"Carrasco","year":"1994","journal-title":"Int J Cardiol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1590\/S0074-02761999000700060","article-title":"Risk of death due to chronic chagasic cardiopathy","volume":"94","author":"Manzullo","year":"1999","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e2176","DOI":"10.1371\/journal.pntd.0002176","article-title":"Mode of death of non-Chagas heart disease: comparison with other etiologies. A subanalysis of the REMADHE trial","volume":"7","author":"Ayoub-Ferreira Mangini","year":"2013","journal-title":"PLoS Neglec Trop Dis."},{"key":"B95","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5935\/abc.20140178","article-title":"Sudden cardiac death in Brazil: a community-based autopsy series (2006-2010)","volume":"104","author":"Braggion-Santos","year":"2015","journal-title":"Arq Bras Cardiol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijcard.2008.05.024","article-title":"Sudden cardiac death in Chagas heart disease in the contemporary era","volume":"131","author":"Bestetti","year":"2008","journal-title":"Int J Cardiol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0002-9149(90)90302-H","article-title":"Angiographic and electrophysiologic substrates of ventricular tachycardia in chronic chagasic myocarditis","volume":"65","author":"de Paola","year":"1990","journal-title":"Am J Cardiol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijcard.2004.03.087","article-title":"Ventricular tachycardia in Chagas disease: a comparison of clinical, angiographic, electrophysiological and myocardial perfusion disturbances between patients presenting with either sustained or nonsustained forms","volume":"102","author":"Sarabanda","year":"2005","journal-title":"Int J Cardiol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1016\/j.jacc.2018.08.2195","article-title":"Long-term prognostic value of myocardial fibrosis in patients with Chagas cardiomyopathy","volume":"72","author":"Senra","year":"2018","journal-title":"JACC."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.jacc.2018.09.035","article-title":"Left ventricular scar and prognosis in chronic Chagas cardiomyopathy","volume":"72","author":"Volpe","year":"2018","journal-title":"JACC."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jacc.2005.06.067","article-title":"Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas disease: a marker of disease severity","volume":"46","author":"Rochitte","year":"2005","journal-title":"JACC."},{"key":"B102","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1590\/S0066-782X2012005000031","article-title":"Delayed enhancement cardiac magnetic resonance imaging can identify the risk for ventricular tachycardia in chronic Chagas heart disease","volume":"98","author":"Mello","year":"2012","journal-title":"Arq Bras Cardiol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.910388\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T05:09:49Z","timestamp":1656479389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.910388\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":102,"alternative-id":["10.3389\/fmed.2022.910388"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.910388","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"article-number":"910388"}}